Filter

Refine by collections

  • Metabolic Syndrome and Diabetes (7)

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 7 of 7 items for :

  • "empagliflozin" x
  • Metabolic Syndrome and Diabetes x
Clear All
Katrine M Lauritsen Steno Diabetes Center Aarhus, Aarhus, Denmark
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Danish Diabetes Academy, Odense University Hospital, Odense, Denmark

Search for other papers by Katrine M Lauritsen in
Google Scholar
PubMed Close
,
Jens Hohwü Voigt Steno Diabetes Center Aarhus, Aarhus, Denmark

Search for other papers by Jens Hohwü Voigt in
Google Scholar
PubMed Close
,
Steen Bønløkke Pedersen Steno Diabetes Center Aarhus, Aarhus, Denmark
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Steen Bønløkke Pedersen in
Google Scholar
PubMed Close
,
Troels K Hansen Steno Diabetes Center Aarhus, Aarhus, Denmark

Search for other papers by Troels K Hansen in
Google Scholar
PubMed Close
,
Niels Møller Steno Diabetes Center Aarhus, Aarhus, Denmark
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Niels Møller in
Google Scholar
PubMed Close
,
Niels Jessen Steno Diabetes Center Aarhus, Aarhus, Denmark
Department of Biomedicine, Aarhus University, Aarhus, Denmark

Search for other papers by Niels Jessen in
Google Scholar
PubMed Close
,
Lars C Gormsen Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Lars C Gormsen in
Google Scholar
PubMed Close
, and
Esben Søndergaard Steno Diabetes Center Aarhus, Aarhus, Denmark
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Danish Diabetes Academy, Odense University Hospital, Odense, Denmark

Search for other papers by Esben Søndergaard in
Google Scholar
PubMed Close

(diabetes duration > 1 year; HbA1c 6.5–9.0% (48–75 mmol/mol) treated with metformin were randomized to empagliflozin 25 mg and placebo once-daily in a randomized, double-blinded, placebo-controlled crossover design. Patients were recruited through

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-21-0558
Volume/Issue:
Volume 11: Issue 4
Open access
Merlin C Thomas Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia

Search for other papers by Merlin C Thomas in
Google Scholar
PubMed Close
,
Brendon L Neuen The George Institute for Global Health, Sydney, NSW, Australia

Search for other papers by Brendon L Neuen in
Google Scholar
PubMed Close
,
Stephen M Twigg The University of Sydney School of Medicine, Sydney, NSW, Australia
Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, NSW, Australia

Search for other papers by Stephen M Twigg in
Google Scholar
PubMed Close
,
Mark E Cooper Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia

Search for other papers by Mark E Cooper in
Google Scholar
PubMed Close
, and
Sunil V Badve The George Institute for Global Health, Sydney, NSW, Australia
Department of Renal Medicine, St George Hospital, Sydney, NSW, Australia
Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia

Search for other papers by Sunil V Badve in
Google Scholar
PubMed Close

sotagliflozin, while kidney function declined in the placebo group (sotagliflozin 0.09 mL/min/1.73 m 2 /year vs placebo −1.31 mL/min/1.73 m 2 /year) ( 14 ). Finally, the EMPA-KIDNEY trial ( 12 ) assessed the effect of empagliflozin compared with placebo in

Article Type:
Review Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-23-0005
Volume/Issue:
Volume 12: Issue 8
Open access
Rama Lakshman Wellcome-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK

Search for other papers by Rama Lakshman in
Google Scholar
PubMed Close
,
Charlotte Boughton Wellcome-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK
Cambridge University Hospitals NHS Foundation Trust, Wolfson Diabetes and Endocrine Clinic, Cambridge, UK

Search for other papers by Charlotte Boughton in
Google Scholar
PubMed Close
, and
Roman Hovorka Wellcome-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK

Search for other papers by Roman Hovorka in
Google Scholar
PubMed Close

limited due to an increased risk of euglycaemic ketoacidosis ( 77 ). In outpatient crossover RCTs utilising the iPancreas AID system, 25 mg empagliflozin daily with HCL led to an increase in time in range compared to HCL alone ( 78 ), and 25 mg

Article Type:
Review Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-23-0132
Volume/Issue:
Volume 12: Issue 8
Open access
Zhenyu Liu Department of Clinical Medicine, Beijing Luhe Hospital, Capital Medical University, Tongzhou District, Beijing, China

Search for other papers by Zhenyu Liu in
Google Scholar
PubMed Close
,
Huixi Kong Department of Clinical Medicine, Beijing Shijitan Hospital, Capital Medical University, Haidian District, Beijing, China

Search for other papers by Huixi Kong in
Google Scholar
PubMed Close
, and
Baoyu Zhang Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Tongzhou District, Beijing, China

Search for other papers by Baoyu Zhang in
Google Scholar
PubMed Close

–after study ( 49 ) SGLT2i Empagliflozin ↓ Δ 36.59 μmol/L for 10 mg Δ 43.55 μmol/L for 25 mg 12 RCTs including 5781 patients with T2DM Meta-analysis ( 53 ) Dapagliflozin ↓ Δ 68.03 μmol/L experiments:29 patients with T2DM controls

Article Type:
Review Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-24-0070
Volume/Issue:
Volume 13: Issue 6
Open access
Jonathan Hazlehurst Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Jonathan Hazlehurst in
Google Scholar
PubMed Close
,
Bernard Khoo Endocrinology, Division of Medicine, University College London, London, UK

Search for other papers by Bernard Khoo in
Google Scholar
PubMed Close
,
Carolina Brito Lobato Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Medicine, Copenhagen University Hospital – Amager and Hvidovre, Hvidovre, Denmark

Search for other papers by Carolina Brito Lobato in
Google Scholar
PubMed Close
,
Ibiyemi Ilesanmi Section of Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK

Search for other papers by Ibiyemi Ilesanmi in
Google Scholar
PubMed Close
,
Sally Abbott Department of Dietetics, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK

Search for other papers by Sally Abbott in
Google Scholar
PubMed Close
,
Tin Chan Faculty of Medicine, Chinese University of Hong Kong, Hong Kong

Search for other papers by Tin Chan in
Google Scholar
PubMed Close
,
Sanesh Pillai Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK

Search for other papers by Sanesh Pillai in
Google Scholar
PubMed Close
,
Kate Maslin School of Nursing and Midwifery, University of Plymouth, Plymouth, UK

Search for other papers by Kate Maslin in
Google Scholar
PubMed Close
,
Sanjay Purkayastha Brunel University, London, UK
Imperial College Healthcare NHS Trust, St Mary’s Hospital, London, UK

Search for other papers by Sanjay Purkayastha in
Google Scholar
PubMed Close
,
Barbara McGowan Endocrinology, Guys’ and St Thomas’s NHS Foundation Trust, London, UK

Search for other papers by Barbara McGowan in
Google Scholar
PubMed Close
,
Rob Andrews University of Exeter Medical School, Exeter, UK

Search for other papers by Rob Andrews in
Google Scholar
PubMed Close
,
Eveleigh Nicholson Portsmouth Hospitals University NHS Trust, Portsmouth, UK

Search for other papers by Eveleigh Nicholson in
Google Scholar
PubMed Close
,
Katherine McCullough Royal Surrey County Hospital, Guildford, UK

Search for other papers by Katherine McCullough in
Google Scholar
PubMed Close
,
Lorraine Albon University Hospitals Sussex NHS Foundation Trust, Worthing, UK

Search for other papers by Lorraine Albon in
Google Scholar
PubMed Close
,
Rachel Batterham Endocrinology, Division of Medicine, University College London, London, UK

Search for other papers by Rachel Batterham in
Google Scholar
PubMed Close
,
Georgios K Dimitriadis King's College Hospital NHS Foundation Trust, London, UK

Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed Close
,
Shareen Forbes BHF Centre for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK

Search for other papers by Shareen Forbes in
Google Scholar
PubMed Close
,
Gavin Bewick School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK

Search for other papers by Gavin Bewick in
Google Scholar
PubMed Close
, and
Tricia M-M Tan Section of Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK

Search for other papers by Tricia M-M Tan in
Google Scholar
PubMed Close

for the latter, but at present, there are no recorded studies or trials of this medication for PBH. In one trial conducted on a small number of people with symptomatic PBH, empagliflozin (a selective SGLT-2 inhibitor) reduced peak postprandial

Article Type:
Other
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-23-0285
Volume/Issue:
Volume 13: Issue 5
Open access
Clemens Kamrath Center of Child and Adolescent Medicine, Justus Liebig University, Giessen, Germany

Search for other papers by Clemens Kamrath in
Google Scholar
PubMed Close
,
Alexander Eckert German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany
Institute of Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany

Search for other papers by Alexander Eckert in
Google Scholar
PubMed Close
,
Birgit Rami-Merhar Department of Pediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria

Search for other papers by Birgit Rami-Merhar in
Google Scholar
PubMed Close
,
Sebastian Kummer Department of General Pediatrics, Neonatology and Pediatric Cardiology, Heinrich Heine University, Medical Faculty, Duesseldorf, Germany

Search for other papers by Sebastian Kummer in
Google Scholar
PubMed Close
,
Martin Wabitsch Center for Rare Endocrine Diseases, Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, Ulm University Medical Centre, Ulm, Germany

Search for other papers by Martin Wabitsch in
Google Scholar
PubMed Close
,
Katharina Laubner Division of Endocrinology and Diabetology, Department of Medicine II, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany

Search for other papers by Katharina Laubner in
Google Scholar
PubMed Close
,
Florian Kopp Forth Clinical Department of Medicine, Academic Teaching Hospital Augsburg, Augsburg, Germany

Search for other papers by Florian Kopp in
Google Scholar
PubMed Close
,
Silvia Müther Center for Pediatric Diabetology, DRK-Kliniken-Berlin Westend, Berlin, Germany

Search for other papers by Silvia Müther in
Google Scholar
PubMed Close
,
Steffen Mühldorfer Department for Gastroenterology, Endocrinology and Metabolic Diseases, Bayreuth University Hospital, Friedrich-Alexander University Erlangen-Nuremberg, Bayreuth, Germany

Search for other papers by Steffen Mühldorfer in
Google Scholar
PubMed Close
, and
Reinhard W Holl German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany
Institute of Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany

Search for other papers by Reinhard W Holl in
Google Scholar
PubMed Close

-glucose cotransporter 2 inhibitor, empagliflozin, in a patient with Rabson-Mendenhall syndrome . Hormone Research in Paediatrics 2021 94 313 – 316 . ( https://doi.org/10.1159/000519613 ) 27 Nagashima S Wakabayashi T Saito N Takahashi M Okada K Ebihara K

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-22-0333
Volume/Issue:
Volume 12: Issue 3
Open access
Qian Deng Graduate College of Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Qian Deng in
Google Scholar
PubMed Close
,
Yue Zhu Graduate College of Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Yue Zhu in
Google Scholar
PubMed Close
,
Mengmeng Zhang Graduate College of Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Mengmeng Zhang in
Google Scholar
PubMed Close
,
Aihua Fei Department of Endocrinology, The Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Aihua Fei in
Google Scholar
PubMed Close
,
Jiaqi Liang Graduate College of Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Jiaqi Liang in
Google Scholar
PubMed Close
,
Jinjin Zheng Graduate College of Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Jinjin Zheng in
Google Scholar
PubMed Close
,
Qingping Zhang College of Acupuncture-moxibustion and Tuina, Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Qingping Zhang in
Google Scholar
PubMed Close
,
Tong Cheng Department of Geriatrics, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Tong Cheng in
Google Scholar
PubMed Close
, and
Xia Ge Department of Endocrinology, The Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Xia Ge in
Google Scholar
PubMed Close

therapeutic implications . Heart Failure Clinics 2019 15 341 – 347 . ( https://doi.org/10.1016/j.hfc.2019.02.003 ) 63 Zhou H Wang S Zhu P Hu S Chen Y Ren J . Empagliflozin rescues diabetic myocardial microvascular injury via AMPK

Article Type:
Review Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-22-0419
Volume/Issue:
Volume 12: Issue 3
Open access